We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+34.39%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$65.8B
AUM Growth
+$8.44B
Cap. Flow
-$768M
Cap. Flow %
-1.17%
Top 10 Hldgs %
21.16%
Holding
3,797
New
262
Increased
1,942
Reduced
1,268
Closed
186

Sector Composition

Rank Sector Weight
1 Technology 10.51%
2 Financials 8.9%
3 Healthcare 8.23%
4 Industrials 6.82%
5 Consumer Discretionary 5.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESV
3426
DELISTED
Ensco Rowan plc
ESV
$66K ﹤0.01%
4,201
-2,952
-41% -$51.5K
GE icon
3427
PUT
GE Aerospace
GE
$380B
$65K ﹤0.01%
2,668
-20,973
-89% -$987K
TTOO
3428
DELISTED
T2 Biosystems, Inc
TTOO
$65K ﹤0.01%
+5
New +$85.1K
NTRP
3429
DELISTED
Neurotrope, Inc. Common
NTRP
$64K ﹤0.01%
11,773
-50
-0.4% -$215
WMT icon
3430
CALL
Walmart Inc
WMT
$897B
$63K ﹤0.01%
357,600
+219,600
+159% +$7.12M
PFX icon
3431
PhenixFIN
PFX
$89.6M
$62K ﹤0.01%
998
JOB icon
3432
GEE Group
JOB
$22.1M
$61K ﹤0.01%
50,853
JPM icon
3433
CALL
JPMorgan Chase
JPM
$956B
$61K ﹤0.01%
176,100
+6,900
+4% +$711K
AUY
3434
DELISTED
Yamana Gold, Inc.
AUY
$61K ﹤0.01%
23,334
-65
-0.3% -$168
MUX icon
3435
McEwen Inc
MUX
$1.18B
$60K ﹤0.01%
4,000
-4,518
-53% -$80K
CLMT icon
3436
Calumet Specialty Products
CLMT
$3.96B
$59K ﹤0.01%
16,699
-300
-2% -$998
CVRS
3437
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$59K ﹤0.01%
34,137
AQMS icon
3438
Aqua Metals
AQMS
$9.7M
$58K ﹤0.01%
+95
New +$52.7K
INO icon
3439
Inovio Pharmaceuticals
INO
$76.1M
$58K ﹤0.01%
1,298
-818
-39% -$41.2K
ADMA icon
3440
ADMA Biologics
ADMA
$2.18B
$56K ﹤0.01%
14,720
-12,151
-45% -$43K
TT icon
3441
CALL
Trane Technologies
TT
$105B
$56K ﹤0.01%
38,800
+11,200
+41% +$1.13M
ZYNE
3442
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$55K ﹤0.01%
10,130
-1,336
-12% -$6.5K
TOO
3443
DELISTED
Teekay Offshore Partners L.P.
TOO
$55K ﹤0.01%
45,670
-16,569
-27% -$20.9K
GGB icon
3444
Gerdau
GGB
$9.74B
$54K ﹤0.01%
17,665
+126
+0.7% +$408
SNNA
3445
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$54K ﹤0.01%
23,226
MEET
3446
DELISTED
The Meet Group, Inc. Common Stock
MEET
$54K ﹤0.01%
+10,740
New +$59.9K
AMRN
3447
CALL
Amarin Corp
AMRN
$298M
$51K ﹤0.01%
+740
New +$267K
SVM
3448
Silvercorp Metals
SVM
$2.7B
$49K ﹤0.01%
+18,998
New +$45.8K
BLNK icon
3449
Blink Charging
BLNK
$86M
$46K ﹤0.01%
14,600
+4,500
+45% +$12K
HD icon
3450
CALL
Home Depot
HD
$350B
$46K ﹤0.01%
69,100
+1,700
+3% +$312K

Similar funds

Raymond James & Associates's Q1 2019 Portfolio in Review

As of Q1 2019, Raymond James & Associates held 3,797 positions worth $65.8B, up 15% from $57.4B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q1 2019 filing shows 262 new, 1,942 increased, 1,268 reduced and 186 closed positions. Its largest new stake was iShares Currency Hedged MSCI Japan ETF: 509,963 shares worth $15.7M. The largest sale was TotalEnergies, an estimated $2.56B.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 9.8% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q1 2019 buy was iShares Currency Hedged MSCI Japan ETF: 509,963 shares worth $15.7M.
  • Raymond James & Associates added most to iShares MSCI USA Min Vol Factor ETF in Q1 2019, an estimated $371M increase.
  • Raymond James & Associates's biggest Q1 2019 reduction was TotalEnergies, cutting an estimated $2.56B.
  • Raymond James & Associates fully exited iShares Core 80/20 Aggressive Allocation ETF in Q1 2019, selling an estimated $26.3M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $65.8B portfolio in Q1 2019.
  • Raymond James & Associates opened 262 new positions and closed 186 in Q1 2019.
  • Raymond James & Associates's portfolio value rose 15% quarter-over-quarter to $65.8B.

Based on Raymond James & Associates's 13F filing for Q1 2019, filed 6 May 2019.